[Skip navigation] FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule

Drug Safety Oversight Board Meeting
February 23, 2006
Public Summary

The Executive Director updated the Board on patient information and healthcare professional sheets (described below as “sheets”) and Public Health Advisories (PHAs) posted since the last meeting, and the Board discussed several of the actions. The drugs for which sheets and/or PHAs were posted included

  • Campath (alemtuzumab)

  • Paxil (paroxetine)

  • Biaxin (clarithromycin)

  • Neutrospec (technetium (99m Tc) fanolesomab)

  • Ketek (telithromycin)

  • Nimotop (nimodipine capsules)

  • Trasylol (aprotinin injection)

  • Benzocaine Sprays marketed under different names, including Hurricaine, Topex, and Cetacaine

The Board also discussed other emerging safety issues and strategies being considered to manage and track identified safety issues in CDER.

       Back to Top   DSOB Meeting Summaries

Date created: March 3, 2006   

horizonal rule

CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page

FDA/Center for Drug Evaluation and Research